Stockreport

IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® Cryoablation [Yahoo! Finance]

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF CAESAREA, Israel Nov. 26, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryo [Read more]